esmolol sold brand name brevibloc cardio selective receptor blocker rapid short duration action significant intrinsic sympathomimetic membrane stabilising activity therapeutic dosages class ii esmolol decreases force rate heart contractions blocking betaadrenergic receptors sympathetic nervous system found heart organs body esmolol prevents action two naturally occurring substances epinephrine patented approved medical use terminate supraventricular tachycardia episodic atrial fibrillation flutter arrhythmia anaesthesia reduce hr bp cardiac surgery early treatment myocardial infarction esmolol also used blunting hemodynamic response laryngoscopy esmolol beta blocker antagonist Î²adrenergic selective receptor intrinsic sympathomimetic esmolol considered soft one rapidly metabolized inactive form esmolol rapidly metabolized hydrolysis ester linkage chiefly esterases cytosol red blood cells plasma cholinesterases red cell membrane acetylcholinesterase total body clearance man found lkghr greater cardiac output thus metabolism esmolol limited rate blood flow metabolizing tissues liver affected hepatic renal blood flow esmolols short duration action based estermethyl side chain allows quick hydrolysis esmolols structure reflected name esmolol estermethyl plasma cholinesterases red cell membrane acetylcholinesterase action metabolism results formation free acid methanol amount methanol produced similar endogenous methanol production esmolol rapid distribution halflife two minutes elimination halflife nine minutescitation needed esmolol classified beta blocker low lipophilicity hence lower potential crossing turn may result fewer effects central nervous system well lower risk neuropsychiatric side httpsenwikipediaorgwikiesmolol